30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Steve Loranger

Track

Insider profile

Currently holds positions in Xylem Inc and Edwards Lifesciences Corp

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 57% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Xylem Inc March 17, 2014 -
Independent Director Edwards Lifesciences Corp March 16, 2016 -
Independent Director FedEx Corp Sept. 25, 2006 - July 13, 2014
President, Chief Executive Officer, Director Xylem Inc Sept. 9, 2013 - March 17, 2014
Steve Loranger's trades of Edwards Lifesciences Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-14 2025-02-14
PrS Proposed sale
98,651
209.38
US$4,517,206 		98,651 209.38 US$4,517,206
2025-02-14 2025-02-14
S Sale
23,086 -11.7%
119.65
US$4,072,082 		23,086 -11.7% 119.65 US$4,072,082
2020-09-15 2020-09-11
US Xylem Inc (XYL)
S Sale
62,061 -17.7%
413.51
US$377,929 		62,061 -17.7% 413.51 US$377,929
2020-02-14 2020-02-12
US Xylem Inc (XYL)
S Sale
30,000 -29.3%
88.61
US$2,658,378 		30,000 -29.3% 88.61 US$2,658,378
2019-03-18 2019-03-15
US Xylem Inc (XYL)
S Sale
10,000 -7.6%
76.99
US$769,917 		10,000 -7.6% 76.99 US$769,917